Imagine a world where cervical cancer becomes a distant memory—eradicated by 2030 through simple, proactive steps. But here's where it gets controversial: Are we doing enough to make life-saving vaccinations accessible to everyone, regardless of gender or cost? Let's dive into the inspiring efforts at King George's Medical University (KGMU) that could change lives, and explore the strategies that might just spark some heated debates.
Doctors at KGMU are wholeheartedly embracing the World Health Organization's (WHO) comprehensive three-part approach—vaccination, screening, and treatment—to bid farewell to cervical cancer as a major public health concern by 2030. This global push gained momentum in 2020 when 194 nations pledged to unite against this preventable disease, turning the tide on what was once a leading cause of cancer-related deaths among women worldwide.
At the forefront of this initiative, Prof. Nisha Singh from the Department of Gynaecological Oncology at KGMU stresses the critical role of HPV (Human Papillomavirus) vaccination. For girls aged 9 to 14, this vaccine is not just recommended—it's essential. HPV is a common virus that can lead to cervical cancer if left unchecked, and vaccinating early helps the body build immunity before exposure. The vaccine's effectiveness ranges from 70% to 80%, offering robust protection against the strains most linked to cancer. In India, it's primarily targeted at girls, but in many other parts of the world, it's administered to boys and girls alike as a gender-neutral measure to prevent transmission and ensure broader community immunity. Prof. Singh notes this difference, suggesting it could be a point of contention: Why limit it to one gender when vaccinating everyone might eliminate the virus more effectively?
The vaccination process is straightforward and affordable. It's given in two doses, spaced six months apart, making it convenient for families. At government hospitals, the cost is just ₹500, a fraction of the ₹4,500 to ₹9,000 charged in private markets. This pricing makes it accessible, but affordability isn't universal—raising questions about whether subsidies should extend further to reach underserved communities.
Moving to the next pillar, regular screening is a non-negotiable for women between 25 and 65 years old. Prof. Singh explains that every woman in this age group should ideally undergo screening every five years after turning 25. However, the bare minimum is two screenings: one around age 35 and another at 45. Think of it like routine check-ups for your car—catching issues early prevents breakdowns. Screening helps detect pre-cancerous changes or early-stage cancer, empowering women with knowledge about their health. If pre-cancer is found, there's no need for drastic measures like a hysterectomy (the removal of the uterus). Instead, simpler procedures like ablation or excision can resolve it quickly, often in an outpatient setting. This early intervention is empowering, turning a potential scare into a manageable blip.
The final component, treatment, caters to those diagnosed with cervical cancer. In early stages, surgery to remove the uterus, ovaries, fallopian tubes, and nearby lymph glands is often the best path. For women hoping to preserve fertility—such as those who haven't started families yet—specialized surgeries can offer options to maintain reproductive potential. In advanced cases, a combination of radiation therapy and chemotherapy becomes necessary. Prof. Singh emphasizes prevention and early detection as the wisest choices, underscoring how timely action can mean the difference between life and a prolonged battle.
Adding depth to this, Prof. Rajeev Gupta, Head of the Department of Radiation Oncology at KGMU, details the tailored procedures. For pre-cancerous stages, minimally invasive surgery targets just the cervix, preserving the rest of the reproductive system. Early cancer detection calls for removing the entire reproductive apparatus surgically. When the disease has progressed, both external radiation (delivered from outside the body) and intracavitary radiation (brachytherapy, where radiation is applied internally to the affected area) are combined for optimal results. This multi-faceted approach, he explains, maximizes effectiveness while minimizing side effects.
Cervical cancer symptoms often emerge in a woman's mid-20s, and Prof. Gupta points to key risk factors that beginners might not immediately consider. Women who marry young and experience multiple pregnancies in quick succession may face heightened vulnerability, as the body hasn't fully recovered between events. Poor personal hygiene, such as inadequate cleaning during menstruation or after childbirth, can also contribute by allowing infections to persist. These factors highlight broader social issues, like access to education on hygiene and family planning. And this is the part most people miss: In cultures where early marriage is common, does society bear responsibility for promoting awareness, or is it too intrusive to challenge traditions?
As we wrap up, consider this thought-provoking question: Should HPV vaccination be mandatory for all children, not just girls, to truly eradicate cervical cancer? Do you think cultural norms around early marriage should be addressed more aggressively in public health campaigns? Share your views in the comments—do you agree, disagree, or have a different take? Your opinions could fuel the debate and help shape future policies!
